OurStoryCarousel

Our Stories

Previous Next

OurStoryTabs

How I Serve Patients Through a Culture of Learning NEW

As a champion of continuous learning, John Ruggiero, Ph.D., leverages the power of diverse voices to create better tomorrows for patients.

View more
Though Born in Germany, Japan is Now “Home” for R&D Leader NEW

In Japanese, the word for home is uchi, うち. For Gerold Meinhardt, M.D., Ph.D., a German native living in the U.S., his true uchi is Japan.

View more
How Embracing My Non-Apparent Disability Helps Me Serve Patients 

After suffering a traumatic brain injury in a motor vehicle accident more than 15 years ago, Barbara Tantillo was challenged to redefine what success looks like as a person living with a non-apparent disability.

View more
My Greatest Professional Adventure—10 Years in the Making

Ken Keller, President & CEO, Daiichi Sankyo, Inc., and Global Head of Oncology Business on the adventure of a lifetime and how each new one shapes who he is.

View more
Those Who Raise You Up: Head of Clinical Science Reflects on Her Role Models

Dalal Nesheiwat discusses her PharmD experience and the role of family and mentorship in her pursuit of a fulfilling career.

View more
Former Heart Surgeon Finds Rewarding Career Outside the OR

Michael Grosso talks open heart surgery, Specialty Medicine, and Astronomy

View more
The Scoop on Our Precision Medicine Global Leader

When one combines their passion for science with the ability to address human suffering, “amazing things” can happen, according to Dale Shuster, Senior Vice President, Global Head of Precision Medicine at Daiichi Sankyo.

View more
Living Her Purpose: Building a Black Breast Cancer Community

Fay Dunbar, our Director of Inclusion & Diversity, sat down with Ricki Fairley to discuss an important topic—advocating for Black women living with breast cancer.

View more
Beyond Innovation, Providing Cancer Survivors What They Need to Thrive

At Daiichi Sankyo, we believe that protecting the well-being of survivors during and after their cancer therapy is just as important as delivering innovative medicines to treat their disease.

View more
How My Veteran Status Serves Our Mission

Neil Albuja, a Senior Director in Finance, shares how military service has shaped his approach to inclusion and diversity.

View more
A Career in Medicine Sparked by a Single Moment

A career of building hope for people with cancer began with a single childhood moment for our Vice President, Global Team Leader, Oncology Research & Development, Dalila Sellami, MD.

View more
Turning Fellowship Into A Fulfilling Healthcare Career

In partnership with the Ernest Mario School of Pharmacy at Rutgers University, Daiichi Sankyo's PharmD fellowship program provides hands-on experience and exposure to the pharmaceutical industry

View more
Looking Towards the Future of Oncology Treatment

At Daiichi Sankyo, Inc., we aim to create essential medicine for longer, better lives. The core and catalyst behind our oncology development plan is our DXd ADC Technology. ADCs, or antibody drug conjugates, are therapies that combine 3 components—an antibody connected to a payload via a linker.

View more
Losing a Partner to Cancer Renewed My Purpose as a Pharmacist

Daiichi Sankyo employee, Eduardo Tozzi, shares his personal story about how he surrounds himself with love each day.

View more
Crafting Cancer Medicines Though the “Lens” of a Compound Microscope

Our Leaders of Innovation: Mark Rutstein, MD, Senior Vice President, Global Head Oncology Clinical Development

View more
How Diversity Contributes to Making Precision Medicine a Reality

CDx leaders born in different corners of the world share their perspectives

View more
Interlaced: Our Purpose Woven into Art

What might look like an ordinary wreath displayed at our U.S. headquarters is a powerful symbol of our collective hope and united purpose—to serve patients with compassion.

View more
An Agile Approach Towards Leading in a Rapidly Changing Environment

As a physician and drug developer, Marielle Cohard-Radice, MD has experienced many challenging opportunities throughout her career that have informed her agile approach to leading during times of change.

View more
Creating a ‘Dream Team’ to Accelerate Development of New Cancer Medicines

Daiichi Sankyo and Sarah Cannon Research Institute (SCRI) announced a strategic collaboration with a goal to work together to accelerate the development of new medicines to improve the standard of care for patients with cancer.

View more
The Advantage Tennis Gave Me as an Inclusion & Diversity Leader

Fay Dunbar, Director of Inclusion & Diversity shares what led her to this work and her vision for an equitable workplace

View more
Closing the Gap in Cancer Care

Partnering with the Oncology Community for Progress

View more
Jazz and Transformative Medicine – the Perfect Harmony

Our Leaders of Innovation: Ken Takeshita, MD

View more
How Our Head of Global Asset and Portfolio Management Leads Teams to Deliver a Pipeline of Innovation

Michele Schmidt, RN, has held in her 20-year plus career in oncology drug development bringing new and innovative medicines to patients

View more
Veterans Across U.S. Help Carry Out Daiichi Sankyo’s Mission

Thanks to our veterans contributing to Daiichi Sankyo’s global mission— to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.

View more
The Many Faces of Breast Cancer

Our dedicated advocacy partners are hard at work developing solutions and providing resources to help these patients, and at Daiichi Sankyo, we share their commitment.

View more
The Art and Science of Making New Medicines

At Daiichi Sankyo, we are invested in addressing complex challenges across the clinical trial process.

View more
The Next Generation of Healthcare Professionals Reflect on Their Internship at Daiichi Sankyo

Our 2022 internship class shares experiences, lessons learned and motivations for a future in healthcare after a summer with Daiichi Sankyo

View more
“In Their Shoes” – The Next Step on Our Patient-Centricity Journey

At Daiichi Sankyo, we believe compassion grows from understanding that no two people suffering from a condition are alike. Each cancer patient has their own set of experiences, challenges and perspectives — a unique story to tell.

View more
The Critical Role of Biomarker Testing

Addressing the gaps in this underutilized but critical component of comprehensive cancer screening

View more
Building a Sense of Belonging for the LGBTQ+ Community

During Pride Month, Daiichi Sankyo commemorates the progress that has been made for equal justice under the law for the LGTBQ+ community, while acknowledging that there is more work to be done to raise awareness and encourage inclusiveness.

View more
APAHM: Embracing Our Heritage, Celebrating Our Diversity

At Daiichi Sankyo we proudly observe Asian Pacific American Heritage Month (APAHM) in May. During this month, we recognize our own Asian heritage—Daiichi Sankyo is a global company based in Japan with more than 100 years of history in medical science.

View more
Daiichi Sankyo’s Special Connection to the Washington, D.C. Cherry Blossoms

Each spring, we’re tickled pink about the role one of our first leaders played in bringing Japanese cherry trees to the U.S. Capital over 110 years ago.

View more
Mentorships Open Windows of Opportunity for Women Across Daiichi Sankyo, Inc.

Lauren and Jennifer are among the 50 mentees who participated in the inaugural year of the Daiichi Sankyo, Inc. Women’s Forum Mentorship Program.

View more
Raising a Hand for the Rare Disease Community

This Rare Disease Day, we hope you will join us in supporting the millions of people across the rare disease community by raising awareness of the resources, programs and support available at rarediseaseday.org.

View more
World Cancer Day 2022: Kicking Off a Three-Year Inequities-Focused Campaign

This February 4, it’s critical for everyone around the globe to come together for World Cancer Day to raise awareness, improve education and spur action around inequities in cancer care.

View more
Honoring Dr. Martin Luther King, Jr.

As we prepare to celebrate the birthday of Dr. Martin Luther King, Jr., we are taking time to reflect on his life and legacy as a man who sowed the seeds of healing in America.

View more
Coming Together as a Community During Blood Cancer Awareness Month and Beyond

Approximately every three minutes, one person in the U.S. is diagnosed with blood cancer. September is Blood Cancer Awareness Month, a time to show our support for these patients and raise awareness of ongoing research to help fight the disease.

View more
Beyond Innovation, Providing Cancer Survivors What They Need to Thrive

At Daiichi Sankyo, we believe that protecting the well-being of survivors during and after their cancer therapy is just as important as delivering innovative medicines to treat their disease.

View more
Closing the Gap in Cancer Care

Partnering with the Oncology Community for Progress

View more
The Many Faces of Breast Cancer

Our dedicated advocacy partners are hard at work developing solutions and providing resources to help these patients, and at Daiichi Sankyo, we share their commitment.

View more
The Art and Science of Making New Medicines

At Daiichi Sankyo, we are invested in addressing complex challenges across the clinical trial process.

View more
“In Their Shoes” – The Next Step on Our Patient-Centricity Journey

At Daiichi Sankyo, we believe compassion grows from understanding that no two people suffering from a condition are alike. Each cancer patient has their own set of experiences, challenges and perspectives — a unique story to tell.

View more
The Critical Role of Biomarker Testing

Addressing the gaps in this underutilized but critical component of comprehensive cancer screening

View more
Raising a Hand for the Rare Disease Community

This Rare Disease Day, we hope you will join us in supporting the millions of people across the rare disease community by raising awareness of the resources, programs and support available at rarediseaseday.org.

View more
World Cancer Day 2022: Kicking Off a Three-Year Inequities-Focused Campaign

This February 4, it’s critical for everyone around the globe to come together for World Cancer Day to raise awareness, improve education and spur action around inequities in cancer care.

View more
Coming Together as a Community During Blood Cancer Awareness Month and Beyond

Approximately every three minutes, one person in the U.S. is diagnosed with blood cancer. September is Blood Cancer Awareness Month, a time to show our support for these patients and raise awareness of ongoing research to help fight the disease.

View more
How I Serve Patients Through a Culture of Learning NEW

As a champion of continuous learning, John Ruggiero, Ph.D., leverages the power of diverse voices to create better tomorrows for patients.

View more
How Embracing My Non-Apparent Disability Helps Me Serve Patients 

After suffering a traumatic brain injury in a motor vehicle accident more than 15 years ago, Barbara Tantillo was challenged to redefine what success looks like as a person living with a non-apparent disability.

View more
My Greatest Professional Adventure—10 Years in the Making

Ken Keller, President & CEO, Daiichi Sankyo, Inc., and Global Head of Oncology Business on the adventure of a lifetime and how each new one shapes who he is.

View more
Living Her Purpose: Building a Black Breast Cancer Community

Fay Dunbar, our Director of Inclusion & Diversity, sat down with Ricki Fairley to discuss an important topic—advocating for Black women living with breast cancer.

View more
How My Veteran Status Serves Our Mission

Neil Albuja, a Senior Director in Finance, shares how military service has shaped his approach to inclusion and diversity.

View more
Turning Fellowship Into A Fulfilling Healthcare Career

In partnership with the Ernest Mario School of Pharmacy at Rutgers University, Daiichi Sankyo's PharmD fellowship program provides hands-on experience and exposure to the pharmaceutical industry

View more
Losing a Partner to Cancer Renewed My Purpose as a Pharmacist

Daiichi Sankyo employee, Eduardo Tozzi, shares his personal story about how he surrounds himself with love each day.

View more
How Diversity Contributes to Making Precision Medicine a Reality

CDx leaders born in different corners of the world share their perspectives

View more
Interlaced: Our Purpose Woven into Art

What might look like an ordinary wreath displayed at our U.S. headquarters is a powerful symbol of our collective hope and united purpose—to serve patients with compassion.

View more
The Advantage Tennis Gave Me as an Inclusion & Diversity Leader

Fay Dunbar, Director of Inclusion & Diversity shares what led her to this work and her vision for an equitable workplace

View more
Veterans Across U.S. Help Carry Out Daiichi Sankyo’s Mission

Thanks to our veterans contributing to Daiichi Sankyo’s global mission— to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.

View more
The Next Generation of Healthcare Professionals Reflect on Their Internship at Daiichi Sankyo

Our 2022 internship class shares experiences, lessons learned and motivations for a future in healthcare after a summer with Daiichi Sankyo

View more
Building a Sense of Belonging for the LGBTQ+ Community

During Pride Month, Daiichi Sankyo commemorates the progress that has been made for equal justice under the law for the LGTBQ+ community, while acknowledging that there is more work to be done to raise awareness and encourage inclusiveness.

View more
APAHM: Embracing Our Heritage, Celebrating Our Diversity

At Daiichi Sankyo we proudly observe Asian Pacific American Heritage Month (APAHM) in May. During this month, we recognize our own Asian heritage—Daiichi Sankyo is a global company based in Japan with more than 100 years of history in medical science.

View more
Daiichi Sankyo’s Special Connection to the Washington, D.C. Cherry Blossoms

Each spring, we’re tickled pink about the role one of our first leaders played in bringing Japanese cherry trees to the U.S. Capital over 110 years ago.

View more
Mentorships Open Windows of Opportunity for Women Across Daiichi Sankyo, Inc.

Lauren and Jennifer are among the 50 mentees who participated in the inaugural year of the Daiichi Sankyo, Inc. Women’s Forum Mentorship Program.

View more
Honoring Dr. Martin Luther King, Jr.

As we prepare to celebrate the birthday of Dr. Martin Luther King, Jr., we are taking time to reflect on his life and legacy as a man who sowed the seeds of healing in America.

View more
Though Born in Germany, Japan is Now “Home” for R&D Leader NEW

In Japanese, the word for home is uchi, うち. For Gerold Meinhardt, M.D., Ph.D., a German native living in the U.S., his true uchi is Japan.

View more
Those Who Raise You Up: Head of Clinical Science Reflects on Her Role Models

Dalal Nesheiwat discusses her PharmD experience and the role of family and mentorship in her pursuit of a fulfilling career.

View more
Former Heart Surgeon Finds Rewarding Career Outside the OR

Michael Grosso talks open heart surgery, Specialty Medicine, and Astronomy

View more
The Scoop on Our Precision Medicine Global Leader

When one combines their passion for science with the ability to address human suffering, “amazing things” can happen, according to Dale Shuster, Senior Vice President, Global Head of Precision Medicine at Daiichi Sankyo.

View more
A Career in Medicine Sparked by a Single Moment

A career of building hope for people with cancer began with a single childhood moment for our Vice President, Global Team Leader, Oncology Research & Development, Dalila Sellami, MD.

View more
Looking Towards the Future of Oncology Treatment

At Daiichi Sankyo, Inc., we aim to create essential medicine for longer, better lives. The core and catalyst behind our oncology development plan is our DXd ADC Technology. ADCs, or antibody drug conjugates, are therapies that combine 3 components—an antibody connected to a payload via a linker.

View more
Crafting Cancer Medicines Though the “Lens” of a Compound Microscope

Our Leaders of Innovation: Mark Rutstein, MD, Senior Vice President, Global Head Oncology Clinical Development

View more
An Agile Approach Towards Leading in a Rapidly Changing Environment

As a physician and drug developer, Marielle Cohard-Radice, MD has experienced many challenging opportunities throughout her career that have informed her agile approach to leading during times of change.

View more
Creating a ‘Dream Team’ to Accelerate Development of New Cancer Medicines

Daiichi Sankyo and Sarah Cannon Research Institute (SCRI) announced a strategic collaboration with a goal to work together to accelerate the development of new medicines to improve the standard of care for patients with cancer.

View more
Jazz and Transformative Medicine – the Perfect Harmony

Our Leaders of Innovation: Ken Takeshita, MD

View more
How Our Head of Global Asset and Portfolio Management Leads Teams to Deliver a Pipeline of Innovation

Michele Schmidt, RN, has held in her 20-year plus career in oncology drug development bringing new and innovative medicines to patients

View more